Renal Failure, Chronic Clinical Trial
Official title:
Effect of Temperature Control During Dialysis Treatment With Glucose in Dialysis Water in Patients With Chronic Renal Failure
The purpose is to measure the effect of glucose in the dialysis water on blood pressure, pulse rate, and plasma glucose with and without body temperature control
To clarify the influence of temperature in dialysis water on blood pressure and vasoactive hormones ;
Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00259025 -
Intravenous n-3 Fatty Acids and Sudden Cardiac Death in Hemodialysis Patients
|
Phase 2 | |
| Completed |
NCT00176059 -
Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients
|
Phase 0 | |
| Completed |
NCT00438503 -
Glucose in Dialysis Water in Diabetics With Chronic Renal Failure
|
Phase 4 | |
| Completed |
NCT00439023 -
Glucose in Dialysis Water in Non-diabetics
|
Phase 4 | |
| Completed |
NCT03904836 -
Tobramycin Administered at the Beginning of Dialysis
|
Phase 1 | |
| Not yet recruiting |
NCT02259296 -
Timing for Arteriovenous Fistula Creation and Its Effect on Target Organs in Patients With Chronic Renal Failure
|
N/A | |
| Completed |
NCT00150891 -
Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection
|
N/A | |
| Completed |
NCT01875523 -
PK of Serelaxin in Severe Renal Impairment and ESRD
|
Phase 1 | |
| Terminated |
NCT00664066 -
DELFT (Dynepo Evaluation of Long-Term Follow-Up Treatment)
|
||
| Withdrawn |
NCT00262353 -
Elimination of Protein-bound Uremic Retention Solutes by Prometheus Artificial Hepatic System Versus Conventional Dialysis
|
N/A |